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Nitric oxide synthase 2, inducible (Nos2) expression is necessary for the microbicidal activity of 
macrophages. However, NOS2 over-activation causes multiple inflammatory disorders, suggesting a 
tight gene regulation is necessary. Using cytosolic flagellin as a model for inflammasome-dependent 
NOS2 activation, we discovered a surprising new role for NLRC4/caspase-1 axis in regulating chromatin 
accessibility of the Nos2 promoter. We found that activation of two independent mechanisms is 
necessary for NOS2 expression by cytosolic flagellin: caspase-1 and NF-κB activation. NF-κB activation 
was necessary, but not sufficient, for NOS2 expression. Conversely, caspase-1 was necessary for NOS2 
expression, but dispensable for NF-κB activation, indicating that this protease acts downstream 
NF-κB activation. We demonstrated that epigenetic regulation of Nos2 by caspase-1 involves cleavage 
of the chromatin regulator PARP1 (also known as ARTD1) and chromatin accessibility of the NF-κB 
binding sites located at the Nos2 promoter. Remarkably, caspase-1-mediated Nos2 transcription and 
NO production contribute to the resistance of macrophages to Salmonella typhimurium infection. Our 
results uncover the molecular mechanism behind the constricted regulation of Nos2 expression and 
open new therapeutic opportunities based on epigenetic activities of caspase-1 against infectious and 
inflammatory diseases.
Innate immune responses rely on Pattern Recognition Receptor (PRR) families responsible for the activation of 
redundant and non-redundant effector responses during infectious and non-infectious degenerative processes. 
Inflammasomes are cytosolic platforms composed of members from the nucleotide-binding oligomerization 
domain (NOD), leucine-rich repeat (LRR)-containing protein (NLR) or the pyrin and HIN domain-containing 
protein (PYHIN) families responsible for the recruitment and activation of inflammatory caspase-1 and 
caspase-11 (caspase-4 in humans), respectively1,2. The complexes containing NLRP1, NLRP3, NLRC4 from NLR 
family and absent in melanoma 2 (AIM2) and pyrin from PYHIN family comprise the best-characterized inflam-
masomes. These platforms are assembled in response to a wide range of pathogen-associated molecular patterns 
(PAMPs), damage-associated molecular patterns (DAMPs) or cytosolic disturbances2. These stimuli induce con-
formational changes in NLR or PYHIN-containing proteins, ultimately leading to recruitment of caspase-1/11 
through homotypical interactions, which may or may not involve the participation of the adaptor molecule ASC 
(apoptosis-associated speck-like protein).
Inflammasomes are central players in a series of infectious diseases and inflammatory processes. However, the 
precise molecular mechanisms involved in the regulation of inflammasomes activation remain to be elucidated3,4. 
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The major effector mechanisms mediated by caspase-1 is the maturation and secretion of pro-inflammatory 
cytokines IL-1β and IL-18 and the induction of a cell death process named pyroptosis. These mechanisms con-
tribute to control infections by inducing strong inflammatory response and recruitment of effector cells, which 
lead to rapid elimination of pathogens replication foci2,5.
In the last years, additional effector mechanisms mediated by inflammasomes have been described, such as 
the secretion of inflammatory mediators, activation of adaptive immune responses and induction of macrophage 
microbicidal activities (Reviewed by ref. 6). Interestingly, many of these responses are shared with other PRRs, 
particularly the transmembrane Toll-like receptors (TLR), including the activation of Nitric Oxide Synthase 2, 
inducible (NOS2). Nos2 expression, and the consequent production of nitric oxide (NO), represents an important 
microbicidal mechanism exploited by the innate immune system. Defects in Nos2 expression have been associ-
ated with enhanced susceptibility to a variety of infectious diseases7. On the other hand, uncontrolled expression 
of Nos2 may lead to the induction of different inflammatory pathologies, such as neurological disorders, liver dys-
functions, atherosclerosis, sepsis and tumors8–10. Thus, activation of inflammasomes, as well as the transcriptional 
activation of Nos2 during infection, must be tightly regulated.
We previously demonstrated that activation of NAIP5/NLRC4 inflammasomes by cytosolic flagellin, the 
structural protein of flagella expressed by motile bacteria, leads to NOS2 activation11. More relevantly, we showed 
that the caspase1/11-induced Nos2 expression plays a key role in the control of intracellular infections11,12. 
However, the precise molecular mechanism of how inflammassome activation regulates Nos2 expression remains 
to be elucidated.
The promoter region of the mouse and human Nos2 gene contains binding sites for several transcription 
factors13–16. However, the induction of Nos2 through inflammatory pathways, such as TLR and IL-1R is mainly 
dependent on nuclear factor kappaB (NF-κ B) (Reviewed by ref. 17). Intriguingly, inflammasome-induced Nos2 
activation occurs independently of IL-1β and IL-18, but requires caspase-1 for its transcriptional regulation11, 
suggesting a novel role of caspase-1 in the regulation of gene transcription.
In fact, here we demonstrated a key role for caspase-1 in regulating chromatin accessibility at the Nos2 gene 
promoter, allowing NF-κ B binding and gene expression upon inflammasome activation, an event that involves 
the cleavage of poly(ADP-ribose) polymerase-1 (PARP1, also known as ADP-ribosyltransferase diphtheria like 1 
(ARTD1)). This novel molecular mechanism of gene expression mediated by caspase-1 has a significant impact 
on the microbicidal capacity of macrophages and may be exploited as an important new avenue for drug discov-
ery and future therapeutic interventions to a variety of diseases related to inflammasome activation.
Results
Activation of NLRC4 inflammasomes by cytosolic flagellin induces NOS2 expression inde-
pendently of MyD88. Cytosolic flagellin is known to activate NAIP5/NLRC4 inflammasomes, leading 
to caspase-1 cleavage, secretion of mature IL-1β , pyroptosis and Nos2 expression (Reviewed by ref. 6). Indeed, 
purified flagellin from Bacillus subtillis inserted into lipid vesicles (FLADot), which allow its delivery to the cell 
cytosol, induced caspase-1 activation (Fig. 1A) and secretion of mature IL-1β by macrophages from C57BL/6 
wild-type (WT) mice (Fig. 1B). Empty lipidic vesicles or flagellin alone (a known TLR5 agonist) did not induce 
caspase-1 activation or secretion of mature IL-1β (Fig. 1A,B and Supplemental Figure 1A). Moreover, induc-
tion of IL-1β secretion by cytosolic flagellin was abolished in macrophages derived from NLRC4−/− mice 
(Supplemental Figure 1A). In addition, as we previously described11, cytosolic flagellin (FLADot) was able to 
induce NOS2 expression (Fig. 1C), which was lost in macrophages from caspase-1/11−/− (casp1/11−/−) but not 
in MyD88−/− cells (Fig. 1C). Conversely, NOS2 induced by free flagellin (FLA) did not require caspase-1/11 and 
occurred in a MyD88-dependent manner (Fig. 1C), suggesting the existence of two independent pathways for 
the induction of Nos2 in response to flagellin. Since MyD88 is a key adapter molecule necessary to transduce the 
signal from TLR5, IL1R and IL18R18,19, our data confirm the activation of NLRC4 inflammasomes by cytosolic 
flagellin induces NOS2 expression that is likely independent of TLR5, IL-1β and IL-18 pathways.
NF-κB activation is required for NLRC4 inflammasome-induced NOS2 expression in response 
to cytosolic flagellin. The induction of NOS2 expression by TLRs or cytokine receptors is a well-described 
process that depends on NF-κ B activation20–23. Our previous findings demonstrate the requirement of caspase-1 
for Nos2 gene and protein expression upon stimulation of macrophages with cytosolic flagellin11. However, the 
molecular mechanism involved in the activation of Nos2 by cytosolic receptors remains to be dissected. Here, we 
found that similarly to TLR agonists (free flagellin or LPS), cytosolic flagellin was also able to induce NF-κ B acti-
vation, as demonstrated by p65 phosphorylation (Fig. 2A), its nuclear translocation (Fig. 2B) and Iκ B-α degrada-
tion (Fig. 2C). To confirm that NF-κ B activation is required for cytosolic flagellin-induced NOS2 expression, we 
used the NF-κ B inhibitor PDTC (Pyrrolidinedithiocarbamate). PDTC inhibits NF-κ B activation by preventing 
Iκ B-α phosphorylation and degradation (Fig. 2C)24. Indeed, NOS2 expression by cytosolic flagellin was abrogated 
in WT as well as in MyD88−/− macrophages in the presence of PDTC (Fig. 2D). Altogether, these data indicate 
that NF-κ B is necessary for cytosolic flagellin-induced NOS2 expression.
Caspase-1 is not required for NF-κB activation but necessary for Nos2 activation in response to 
flagellin. Since NOS2 induced by cytosolic flagellin required both caspase-1 and NF-κ B, we hypothesize that 
caspase-1 acts through NF-κ B to induce NOS2 expression. Surprisingly, we observed that even in the absence 
of caspase-1, cytosolic flagellin was still able to activate NF-κ B (Fig. 3A,B). Macrophages derived from WT and 
casp1/11−/− showed similar kinetics of p65 phosphorylation, which was detectable by 10 minutes after cytosolic 
flagellin stimulation (Fig. 3A). Similarly to WT cells (Fig. 2B), Iκ B-α degradation was also observed in mac-
rophages from casp1/11−/− mice, 30 minutes after cytosolic flagellin stimulation (Fig. 3B).
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Although caspase-1 was dispensable for NF-κ B activation, it was required for robust Nos2 expression and acti-
vation. Macrophages derived from casp-1/11−/− mice (and cells treated with z-YVAD-fmk11) showed impaired 
expression of NOS2, both at the protein (Fig. 1C) and mRNA (Fig. 3C) levels, upon stimulation with cytosolic 
flagellin. Accordingly, macrophages from WT mice (Fig. 3D), but not from casp1/11−/− mice (Fig. 3G), were able 
to secrete high levels of NO in response to the infection with the intracellular bacteria Salmonella typhimurium 
(S. typhimurium). Lower levels of NO was observed in response to flagellin-deficient (Δ FliC) mutant S. typh-
imurium compared to wild type bacteria (Fig. 3D), which correlated with the higher CFU numbers recovered 
from these cultures (Fig. 3E). The addition of AG, a pharmacological inhibitor of NOS2, significantly increased 
the number of CFU observed in cultures infected with wild type but not Δ FliC S. typhimurium (Fig. 3E), sug-
gesting a role for cytosolic flagellin-mediated NO secretion to the control of S. typhimurium by macrophages. 
To further confirm the requirement of flagellin we added cytosolic flagellin to these macrophages infected with 
Δ FliC S. typhimurium. As expected, cytosolic flagellin induced an increase in the NO secretion (Fig. 3D), which 
resulted in the better control of infection (Fig. 3E). Again, this effect was reverted by the addition of AG (Fig. 3E), 
demonstrating that the non-canonical induction of Nos2 via cytosolic flagellin is important to the control of 
S. typhimurium infection.
As expect, in comparison to Δ FliC S. typhimurium, wild type S. typhimurium also induced higher frequencies 
of cells that incorporated Ethidium Bromide (EtBr) and lost the staining for Acridine Orange (AO) (Fig. 3F), a 
phenomenon consistent with the induction of pyroptosis25. Similar as observed for NO production, the addition 
of purified cytosolic flagellin resulted in increased cell death in Δ FliC S. typhimurium-infected macrophages. 
Importantly, AG did not inhibit cell death in any situation (Fig. 3F). Conversely, a slight higher frequencies in cell 
death was observed in the presence of AG during infection with Δ FliC S. typhimurium (Fig. 3F), which could 
be explained by the increased numbers of CFU (Fig. 3E), since AG had no effect on cell death in the absence of 
Figure 1. Cytosolic flagellin induces NOS2 expression in a Myd88-independent and casp1/11-dependent 
manner. Starch-elicited peritoneal macrophages (PMs) isolated from C57BL/6 WT mice were stimulated 
with flagellin from Bacillus subtilis inserted on DOTAP (Dot) (FLADot) [3 μ g/mL] for 6 hr. (A) Caspase-1 
activation (p20) and (B) mature IL-1β secretion (p17) were assessed by western blotting in total cell extracts and 
supernatants. Cells were stimulated with lipid vesicle empty (Dot) as negative control. (C) PMs from C57BL/6 
WT, casp1/11−/− and MyD88−/− mice were stimulated with Dot, FLA [3 μ g/mL] or FLADot [3 μ g/mL] for 24 hr 
and NOS2 expression was analyzed by western blotting in total cell extracts. Western blot densitometric analysis 
was performed using ImageJ software and Nos2 relative expression was normalized according to β -actin 
expression. Data are representative from at least three independent experiments.
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infection (data not shown) or during infection with wild type S. typhimurium (Fig. 3F). These results demonstrate 
that flagellin-induced NO secretion acts through a non-redundant manner with pyroptosis to optimize the con-
trol of S. typhimurium by macrophages.
Importantly, although cytosolic flagellin is also able to induce a caspase 1/11-independent inflammatory 
form of cell death25, NO secretion was not observed in macrophages from casp1/11−/− in all above situations 
(Fig. 3G), confirming the relevance of the caspase-1/11-induced NOS2 activation to the control of S. typhimurium 
by macrophages. Notably, casp1/11−/− macrophages were fully able to secrete NO in response to rIFN-γ plus LPS 
(Fig. 3H), thus indicating these cells have no intrinsic defect in Nos2 processing. Altogether, these results suggest 
that caspase-1 is dispensable for the activation of NF-κ B, however, its induction is necessary for robust NOS2 
activation in response to cytosolic flagellin.
PARP1 cleavage is required for cytosolic flagellin-induced Nos2 expression. Up to this point, 
our data demonstrated that NF-κ B activation is necessary but not sufficient for Nos2 expression in response to 
cytosolic flagellin. Moreover, our data suggested that caspase-1 is necessary for Nos2 expression downstream of 
NF-κ B activation. Thus, we hypothesize that caspase-1 may play a role in regulating the chromatin accessibility 
for NF-κ B binding to the regulatory elements of the Nos2 promoter. Corroborating our hypothesis, recently 
published work demonstrated that caspase-7 activation by LPS can lead, in a non-apoptotic manner, to PARP1 
Figure 2. Cytosolic flagellin induces NF-κB activation that is required for NOS2 expression. (A) PMs 
from C57BL/6 WT mice were stimulated with Dot, FLADot [3 μ g/mL] or LPS [1 μ g/mL] as indicated for 5 to 
60 minutes and the phospho p65-NF-κ B subunit was analyzed by western blotting. (B) BMDMs from C57BL/6 
WT mice were stimulated with Dot, LPS [100 ng/mL] or FLADot [3 μ g/mL] for 30 min and p65-NF-κ B  
nuclear translocation was assessed by immunofluorescence microscopy. (C) Iκ B-α degradation was assessed 
by western blotting 30 min after stimulations. (D) PMs from WT and MyD88−/− mice were stimulated with 
FLADot [3 μ g/mL] in the presence or absence of PDTC for 24 hr. Total cell extract was prepared and NOS2 were 
analyzed by western blotting. Western blot densitometric analysis was performed using ImageJ software and 
NOS2 relative expression was normalized according to β -actin expression. Data are representative from at least 
three independent experiments.
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cleavage, resulting in chromatin decondensation, which promotes the transcription of a specific set of NF-κ B tar-
get genes, such as Csf2, Il-6 and Lif but not Ip-1026. However, in response to cytosolic flagellin, caspase-1/11 seems 
to play a central role in promoting the transcription of Nos2, since casp7−/− macrophages present only a minor 
defect in the induction of Nos2 expression in comparison to casp1/11−/− cells (Fig. 4A).
To evaluate the involvement of PARP1 cleavage in the transcriptional activation of Nos2 by cytosolic flagellin, 
we took advantage of knockin PARP1D214N mice (Fig. 4B), in which PARP-1 is uncleavable even in the presence 
of a highly inflammatory stimulus, such as LPS (Fig. 4C). Interestingly, macrophages derived from PARP1D214N 
mice fail to robustly up-regulate Nos2 after cytosolic flagellin stimulation (Fig. 4D). Importantly, the requirement 
of PARP1 cleavage seems to be specific for the Nos2 gene since the transcription of other genes, such as Iκ B-α 
(Fig. 4E) and Ip-10 (Fig. 4F), were not affected after exposure of PARP1D214N macrophages to cytosolic flagellin, 
indicating that NF-κ B activation is intact in these cells. These results imply that PARP1 cleavage is required for 
Figure 3. Caspase-1/11-dependent NOS2 activation is involved in the control of S. Typhimurium infection by 
macrophages. (A) PMs from C57BL/6 and casp1/11−/− mice were stimulated with Dot or FLADot [3 μ g/mL] for 
indicated times and the phospho p65-NF-κ B subunit was analyzed by western blotting. (B) Iκ B-α degradation was 
assessed by western blotting in PMs from casp1/11−/− mice 30 minutes after Dot and FLADot stimulations.  
(C) Bone marrow derived macrophages (BMDM) from C57BL/6 and casp1/11−/− mice were stimulated with 
Dot or FLADot [3 μ g/mL] for 3–4 hr and mRNA levels were determined by real-time RT-PCR. Samples were 
normalized to GAPDH expression levels. (D) PMs from C57BL/6 or (G) casp1/11−/− mice were infected with  
the flagellin-suficient S.Typhimurium 1412 strain (WT) or the flagellin deficient S. Typhimurium 2157 strain –  
Δ FliC) (3 × 104 bacteria per 3 × 105 macrophages) for 1 hr in the presence or absence of aminoguanidine (AG). 
After infection, cultures were treated with gentamicine [50 μ g/ml] for 50 min to eliminate extracellular bacterial 
and maintained with 5 μ g/ml of gentamicin for 24–48 hr in the presence of purified S. Tyhimurium-derived flagellin 
inserted into DOTAP (FliDot) [1 μ g/mL] as indicated. NO production was assessed by Griess methods in culture 
supernatants after 48 hr. (E) CFU counting from C57BL/6 PMs infected with WT or Δ FliC S. Typhimurium after 
24 hr. (F) Cytotoxicity was assessed as the percentage of EtBr single-positive cells in fluorescence micrographs 
according to AO/EtBr staining after 24 hr of infection. Numbers represent the means ± SEM of at least 16 images 
per treatment. (H) PMs from C57BL/6 WT and casp1/11−/− mice were stimulated with (− ) or rIFN-γ [2,5 ng/mL] 
for 24 hr and NO production was assessed by Griess methods in culture supernatants. Bars represent the mean S.D. 
of triplicate samples. Data are representative of three independent experiments. **p > 0.01; ***p < 0.001.
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Nos2 transcriptional activation in response to cytosolic flagellin, suggesting caspase-1 is regulating the access of 
NF-κ B to its binding sites at the Nos2 gene promoter region.
Binding sites of NF-κB in the Nos2 gene promoter are not accessible in the absence of 
caspase-1/11. Using public available ChIP-seq data for NF-κ B in bone marrow-derived dendritic cells 
(BMDC) stimulated with LPS (GSE36104)27, we were able to identify enrichment of NF-κ B binding to the Nos2 
gene promoter between 30 to 120 minutes after LPS treatment (Fig. 5A). We performed motif analysis on these 
NF-κ B peaks around the Nos2 gene promoter and identified two putative NF-κ B binding sites (Fig. 5A–D). Next, 
we used the Assay for Transposase-Accessible Chromatin (ATAC) coupled with qPCR in order to evaluate the 
accessibility of chromatin around these putative NF-κ B binding sites of the Nos2 gene. We designed one primerset 
between the two NF-κ B binding sites (primerset 2), one primerset upstream (primerset 1) and two primersets 
downstream (primerset 3 and 4). We observed that cytosolic flagellin robustly increased chromatin accessibil-
ity at the Nos2 gene promoter in BMDM from WT mice, especially in the regions close to the NF-κ B bind-
ing sites (Fig. 5E–H, white bars). However, in the absence of caspase-1/11, cytosolic flagellin lost its ability to 
increase chromatin accessibility at the Nos2 gene promoter (Fig. 5E–H, black bars). These results are unlikely to 
be caused by global change in chromatin accessibility in the casp1/11−/− cells since we could not observe changes 
in chromatin accessibility for our positive and negative controls between WT and casp1/11−/− (Fig. 5I). Notably, 
cytosolic flagellin also failed to increase the accessibility of chromatin at the Nos2 gene promoter in NLRC4−/− 
macrophages (Supplemental Figure 1B–E), demonstrating that NLRC4/caspase-1 axis is central in the epigenetic 
regulation of Nos2 gene transcription in response to cytosolic flagellin. To sum up, our results describe a key 
regulatory role of caspase-1 on chromatin accessibility at the Nos2 gene promoter upon NLRC4 inflammasome 
activation. This increased chromatin accessibility allows NF-κ B binding and transcriptional activation of Nos2.
Discussion
Inflammasomes are immune platforms that lead to caspase-1 activation in response to a wide range of stim-
uli, including bacterial, protozoan, viral and fungal infections28–31. Active caspase-1 mediates a series of effector 
responses required for the control of infections. Among these effector responses, expression of Nos2 through 
inflammasomes is involved in the control of Legionella pneumophila11, Trypanosoma cruzi12, Leishmania spp32 
and Salmonella Typhimurium (Fig. 3). However, overactivation of NOS2 can cause tissue damage and consequent 
Figure 4. NLRC4 inflammasome-induced Nos2 expression in response to cytosolic flagellin requires 
PARP1 cleavage at D214N site. (A) Bone marrow derived macrophages (BMDM) from C57BL/6, casp1/11−/− 
and casp7−/− mice were stimulated with Dot or FLADot [3 μ g/mL] for 3–4 hr and mRNA levels were 
determined by real-time RT-PCR. Samples were normalized to GAPDH expression levels. (B) Schematic 
representation of the point mutation in the cleavage site for caspases in the PARP1 molecule present in 
PARP1D214N mice and its consequence for chromatin modulation. (C) BMDM isolated from C57BL/6 WT and 
PARP1D214N mice were stimulated with LPS [100 ng/mL] for 6 hr. Total cell extracts were prepared, and PARP1 
cleavage was analyzed by western blotting. BMDM from C57BL/6 WT and PARP1D214N mice were stimulated 
with FLADot [3 μ g/mL] for 3–4 hr and mRNA levels of Nos2 (D), Iκ B-α (E) and IP-10 (F) were determined 
by real-time RT-PCR analysis. WT and PARP1D214N samples were normalized to their GAPDH expression 
levels and expressed as relative mRNA levels. Bars represent the mean ± SEM of triplicate samples. Data are 
representative of three (A and C) or five (D–F) independent experiments. **p > 0.01; ***p < 0.001.
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inflammatory pathologies such as asthma, cardiovascular and neurological diseases, liver and renal dysfunc-
tions, atherosclerosis, tumors, coagulation disorders, sepsis, among others8,33–35. Both microbicidal activity and 
the development of inflammatory pathologies are a result of the key role of NO and peroxynitrite (ONNO−), a 
powerful free radical formed by the reaction of NO with superoxide (O2−), in the modification of a wide range 
of different proteins8,36,37. Therefore, understanding the molecular mechanisms that lead to Nos2 activation may 
allow the development of therapeutic strategies aiming to increase its activation in case of infections or reduce its 
activation in inflammatory pathologies.
The induction of Nos2 expression by TLRs or cytokine receptors is a well-described process that depends on 
NF-κ B activation20–23. However, activation of Nos2 by cytosolic receptors is significantly less known. Our previ-
ous findings demonstrate the requirement of caspase-1 for Nos2 gene and protein expression upon stimulation 
Figure 5. Binding sites of NF-κB at the Nos2 gene promoter are not accessible in the absence of 
caspase-1/11. (A) Bone marrow-derived dendritic cells (BMDC) were stimulated with LPS [100 ng/ml] for  
30–120 min and the enrichment of NF-κ B binding to the Nos2 gene promoter was identified using public 
available ChIP-seq data. (A–D) Identification of two putative NF-κ B binding sites around the Nos2 promoter. 
(E–H) Bone marrow-derived macrophages (BMDM) from WT or casp1/11−/− were stimulated with Dot or 
FLADot and after 3 h the chromatin accessibility at the Nos2 gene promoter was analyzed using Transpoase-
Accessible Chromatin Assay (ATAC) coupled with qPCR. (I) Positive control of chromatin accessibility in 
BMDM stimulated as indicated.
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of macrophages with cytosolic flagellin11. Here we dissected this molecular mechanism and found that robust 
expression of Nos2 by stimulation of macrophages with cytosolic flagellin is dependent on two pathways (Fig. 6). 
First, cytosolic flagellin was able to induce NF-κ B, in a process independent of caspase-1 that was required, but 
not sufficient, for robust Nos2 expression. Second, activation of the NLRC4 inflammasomes by cytosolic flagellin 
was able to activate caspase-1, leading to cleavage of PARP1 and subsequent increased chromatin accessibility at 
the NF-κ B binding sites of the Nos2 promoter.
The exact mechanism by which cytosolic flagellin activates NF-κ B remains to be elucidated. However, it does 
not require caspase-1. Importantly, the inhibition of NF-κ B also abrogated NOS2 expression in response to cyto-
solic flagellin in macrophages from MyD88−/− mice. Since NOS2 activation in response to cytosolic flagellin was 
preserved in MyD88−/− macrophages, it suggests that the activation of caspase-1/NF-κ B axis involved in the 
induction of Nos2 occurs independently of TLR5, IL-1R, IL-18R pathways.
Although IL-1β and IL-18 are the best-studied caspase-1 substrates, it is well documented that caspase-1 also 
cleave less conventional substrates, including PARP138. PARP1 catalyzes the polymerization of ADP-ribose units 
from donor NAD+molecules39,40. During apoptosis and pyroptosis, PARP1 is cleaved by caspases, resulting in the 
release of two fragments (24 and 89 kDa) and the inactivation of the enzymatic activity38,41. Although historically 
studied in the context of genotoxic stress signaling and apoptosis, PARP1 has recently been linked to the regu-
lation of chromatin structure, transcription, and chromosome organization26,42,43. These findings came from the 
observations that PARP1D214N mice developed normally, indicating that cleavage of PARP1 is not required during 
apoptosis44 but is more likely required for other important cellular functions. In fact, increasing numbers of stud-
ies have provided evidence that PARP1 can regulate gene expression also independently of its enzymatic activity, 
especially by inducing structural chromatin changes (reviewed by ref. 45). Under steady state conditions, PARP1 
maintains chromatin in a condensed state, thus dampening transcriptional activation of genes. However, under 
inflammatory or stress conditions, PARP1 is cleaved by caspases, which could promote its eviction from the chro-
matin and subsequently a local chromatin decondensation, leaving the DNA accessible for transcription factors. 
In this context, Erener et al.26 demonstrated the cleavage of PARP1 by caspase-7 promote the transcription of a 
specific set of NF-κ B target genes, such as Csf2, Il-6 and Lif but not Ip-10. In our system, caspase-1 seems to have 
a significant higher impact than caspase-7 on Nos2 expresson, pointing caspase-1 activation and PARP1 cleavage 
as central events in the regulation of Nos2 transcription in response to cytosolic flagellin.
Altogether, we provided strong evidence for the molecular mechanism that regulates Nos2 expression 
upon inflammassome activation. This mechanism is dependent on NLRC4/caspase-1, PARP1 cleavage, and 
NF-κ B activation. Our data suggests that the increased chromatin accessibility at Nos2 promoter is caused by 
caspase-1-dependent cleavage of PARP. However, further experiments are necessary to establish a direct link 
between PARP cleavage and increased chromatin accessibility at Nos2 promoter by cytosolic flagelin. Importantly, 
stimulation of macrophages with cytosolic flagellin, even in the absence of caspase-1/11, does not activate the 
apoptosis program25, which supports the non-apoptotic role of PARP-1 in gene regulation. Similar as found 
Figure 6. NLRC4 inflammasomes regulate chromatin accessibility at the Nos2 gene promoter in 
response to cytosolic flagellin by an event that involves PARP-1 cleavage. Cytosolic flagellin induces 
NAIP5/NLRC4-caspase-1 pathway, and in parallel, activates NF-κ B transcription factor by an unknown 
mechanism. Inflammasome activation leads to the cleavage of PARP1, which, in its turn, is likely released 
from the chromatin, resulting in chromatin decondensation and consequently NF-κ B-dependent Nos2 
gene transcription. The product of NOS2 expression (nitric oxide) is involved in the control of intracellular 
replication of pathogens in macrophages.
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during the activation of NLRC4 inflammasomes by S. typhimurium, the activation of NLRP3 with ATP or 
nigericin also induces the cleavage of PARP1 in a NLRP3, ASC and caspase-1- dependent manner38, although it 
remains to be elucidated the involvement of NLRP3 in the epigenetic regulation of Nos2. It is important to note 
that PARP1 cleavage seems to have only a minor or no effect on pyroptosis and IL-1β secretion, respectively, in 
response to the activation of NLRP3 and NLRC4 inflammasomes38, reinforcing the idea that cell death and epige-
netic regulation are independent events mediated by caspases/PARP1 axis.
Remarkably, our data clear demonstrated that the NLRC4 inflammasome-mediated epigenetic regulation of 
Nos2 is essential for its full activation and biological properties, such as macrophage microbicidal capacity. It is 
well known that inflammatory processes of cell death induced by cytosolic flagellin are important NAIP5/NLRC4 
inflammasomes-mediated effector mechanisms involved in the control of infections5,25. The delivery of flagellin 
into cell cytosol leads to caspase-1/11-dependent and -independent forms of cell death25, even though the major-
ity of cells remains alive, especially at early time points after stimulation11,25, likely accounting for the upregulation 
in the Nos2 gene. Importantly, the pharmacological inhibition of NO production in response to S. typhimurium 
and cytosolic flagellin resulted in a significant increase in the CFU numbers recovered from the macrophage 
cultures without inhibiting cell death. Therefore, even if it remains to be elucidated the relative contribution of 
the events induced by cytosolic flagellin in a single cell, our results strongly suggest that NOS2 activation and 
pyroptosis are independent effector mechanisms induced by NLRC4 inflammasomes that contribute to control 
intracellular infections.
Both Nos2 and inflammasome activation are considered double-edged sword arms of immune responses, 
since in addition to their role to control infections, the overactivation of both mechanisms can cause tissue dam-
age and consequent inflammatory pathologies such as asthma, cardiovascular and neurological diseases, liver 
and renal dysfunctions, atherosclerosis, tumors, coagulation disorders, sepsis, among others8,33–35. Therefore, the 
description of a novel role for caspase-1 on the epigenetic regulation of gene transcription could open up new 
perspectives in the therapeutic interventions for inflammatory disorders caused by uncontrolled activation of 
inflammasomes.
Methods
Mice and Cell Isolation. WT, casp-1/11−/−, NLRC4−/− and transgenic mice (uncleavable PARP1 
(PARP1D214N)) were bred from the same genetic background (C57BL/6) in our animal facilities at Federal 
University of São Paulo or the University of Zurich and maintained in a specific pathogen-free facility. All ani-
mal experiments were carried out in accordance with the Swiss, EU and Brazil ethical guidelines and have been 
approved by the local animal experimentation committee of the Canton of Zurich, Federal University of São 
Paulo and University of São Paulo under licenses #2012207, 0159–11 and 109/51-2, respectively, following the 
3R guidelines. For the isolation of peritoneal macrophages (PMs), 9- to 12-week-old mice were i.p injected with 
2 ml of 1,5% Starch solution (Sigma) from potatoes for 4 days. Mice were euthanized, cells were collected in cold 
PBS by abdominal lavage, and seeded in tissue culture plates (Costar) in full-RPMI medium containing 3% FCS, 
100 units/ml penicillin/streptomycin, 1 mM sodium pyruvate and 2 mM L-glutamine and incubated at 37 °C and 
5% CO2. All supplements were purchased from Invitrogen. The non-adherent cells were removed by vigorous 
washes with RPMI medium.
For the generation of bone marrow-derived macrophages (BMDM), 9–12 week-old mice were euthanized, 
and cells isolated as described elsewhere46. Briefly, cells were plated in 10 cm uncharged plastic plates (Petri dish) 
and incubated for full differentiation in RPMI medium supplemented with 10% FCS, 100 units/ml penicillin/
streptomycin, 1 mM sodium pyruvate, 2 mM L-glutamine, 50 mM b-mercaptoethanol, and 20% L929 conditioned 
medium for 7 days in a humidified incubator (with 5% CO2 at 37 °C). After 7 days, cells were counted and seeded 
in 24-well tissue culture plates. After 16 hr, cells were stimulated as indicate.
Stimulation of macrophages with flagellin. PM (3 × 105) or BMDM (5 × 105) were stimulated with 
purified flagellin from Bacillus subtilis or S. Typhimurium (Invivogen) [1–3 μ g/ml] in its free form (FLA) or 
inserted into DOTAP (Dot) (Roche Diagnostics) (FLADot), a cationic lipid vesicle formulation that permits its 
delivery to cell cytosol and was used accordingly to the manufacturer’s instructions. Briefly, DOTAP (50 μ l) was 
incubated for 15 min in serum-free media with 9 μ g of purified flagellin. After incubation, 2.95 ml of RPMI 1640 
medium was added, and an aliquot of 200 μ l was added to 3 × 105 macrophages (for 3 μ g/ml final concentration).
Bacterial Infection. Flagellin-suficient S.typhimurium 1412 strain (WT) or flagellin-deficient S. typhimu-
rium 2157 strain (Δ FliC) were cultured overnight in L-broth at 37 °C with shaking. Then, bacteria were diluted 
1:20 into L-broth, grown at 37 °C with shaking for 3 h, washed and resuspended in 0.9% NaCl saline before infec-
tion. Adherent PMs from C57BL/6 or casp1/11−/− mice were infected at 1:10 multiplicity of infection (MOI) 
in antibiotic-free supplemented RPMI medium, in the presence or absence of 1 mM aminoguanidine (AG), a 
selective NOS2 inhibitor, centrifuged at 2000 rpm × 10 min to synchronize the infection and allowed to invade 
for 1 hr in the CO2 incubator. After infection, cultures were treated with gentamicin [50 μ g/ml], in the presence 
or absence of AG, for 50 min to eliminate extracellular bacteria. Next, cultures were maintained with 5 μ g/ml of 
gentamicin in the presence or absence of AG and purified S. typhimurium flagellin inserted into DOTAP (FliDot) 
[1 μ g/mL], for 24–48 hr.
Cytokine and Nitric Oxide measurement. IL-1β was measured in culture supernatants by enzyme-linked 
immunoabsorbent assay (ELISA) (kits from BD Biosciences) following the manufacturer’s instructions. Culture 
supernatants of S. Typhimurium-infected PMs were assayed for nitric oxide by the Griess reaction. Briefly, 50 μ l 
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7:41686 | DOI: 10.1038/srep41686
of supernatant was incubated with 50 μ l of Griess reagent for 5 min at room temperature. Nitrite concentration 
was determined by measuring the optical density at 550 nm in reference to a standard sodium nitrite solution.
Western Blotting. Western blot was performed as previously described47. Cells were harvested, washed 
once in ice-cold PBS, lysed directly in SDS sample buffer (50 mMTris-HCl, pH 6.8, 2% SDS, 10% glycerol, and 
2.5% L-mercaptoethanol), and boiled for 5 min. Samples were resolved under reducing conditions for 2–4 h at 
100–120 V in SDS-polyacrylamide gels, according to its protein size. Proteins were then transferred onto PVDF 
membranes in a semi-dry system. Blots were blocked for 1 h in TBST (10 mMTris-HCl, pH 7.4, 150 mMNaCl, and 
0.05% Tween) containing 0.1% sodium azide and 5% nonfat dried milk and then probed with polyclonal or mon-
oclonal antibodies. Reactions were detected with suitable secondary antibody conjugated to horseradish peroxi-
dase (The Jackson Laboratory and Amersham Biosciences) using enhanced chemiluminescence solution (Pierce).
Cell cytotoxicity assay. Cell cytotoxicity was assessed using ethidium bromide (EtBr) incorporation in 
combination with acridine orange (AO) (Sigma) staining as described previously25. AO is a vital dye while EtBr 
is only incorporated by cells that lost membrane integrity. After 6–24 hr of stimulation or infection, the culture 
supernatants were removed, and a solution of PBS containing EtBr and AO (25 ng/mL; vol/vol) was added to cells. 
Images were acquired using an inverted fluorescence microscope with original magnification of 200 × . The per-
centage of EtBr single positive cells, representing the percentage of cell death, was analyzed using NIS-Elements 
Microscope (NIKON) software.
RNA Extraction and Gene Expression Analysis by Real-Time RT-PCR. Confluent (90%) BMDM 
were stimulated with 3 μ g/ml of Dot or FLADot for 3–4 hr. Total RNA was isolated using kits according to the 
manufacturers’ recommendation (Macherey-Nagel and Ambion). RNA was reverse-transcribed (kit from Applied 
Biosystems) and real-time PCR was performed using the Rotor-Gene 3000 (Corbett Life Science/QIAGEN) and 
TaqMan assays or SYBR Green.
Chromatin Accessibility by ATAC-qPCR. Adherent PMs from C57BL/6 or casp1/11−/− mice from each 
biological replicate were used to perform ATAC (assay for transposase-accessible chromatin) as previously 
described3. ATAC was performed on 5 × 105 cells with Nextera DNA Sample Preparation Kit (FC-121-1030, 
Illumina). Total DNA was extracted and used as input. Validation of enrichment of open chromatin in the ATAC 
samples over input was performed by qPCR, testing the open chromatin genes TARS and beta-actin, and the 
closed chromatin markers RhO and CHEK2. Four primer sets covering the promoter region of Nos2 was used to 
investigate the chromatin accessibility before and after flagellin infection. The primers used for ATAC-qPCR are 
described in Table S1.
References
1. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and 
processing of proIL-beta. Molecular cell 10, 417–426 (2002).
2. Broz P. & Dixit V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 16(7), 407–20 
(2016).
3. Gallo, M. et al. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing 
Chromatin. Cancer Cell 28, 715–729 (2015).
4. Saavedra, P. H., Demon, D., Van Gorp, H. & Lamkanfi, M. Protective and detrimental roles of inflammasomes in disease. Seminars 
in immunopathology 37, 313–322 (2015).
5. Jorgensen, I. & Miao, E. A. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev 265, 130–142 (2015).
6. Lage, S. L. et al. Emerging Concepts about NAIP/NLRC4 Inflammasomes. Front Immunol 5, 309 (2014).
7. Bogdan, C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol 36, 161–178 (2015).
8. Pacher, P., Beckman, J. S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87, 315–424 (2007).
9. Cheng, H. et al. Nitric oxide in cancer metastasis. Cancer Lett 353, 1–7 (2014).
10. Garry, P. S., Ezra, M., Rowland, M. J., Westbrook, J. & Pattinson, K. T. The role of the nitric oxide pathway in brain injury and its 
treatment–from bench to bedside. Exp Neurol 263, 235–243 (2015).
11. Buzzo, C. L. et al. A novel pathway for inducible nitric-oxide synthase activation through inflammasomes. The Journal of biological 
chemistry 285, 32087–32095 (2010).
12. Goncalves, V. M. et al. NLRP3 Controls Trypanosoma cruzi Infection through a Caspase-1-Dependent IL-1R-Independent NO 
Production. PLoS Negl Trop Dis 7, e2469 (2013).
13. Hecker, M., Cattaruzza, M. & Wagner, A. H. Regulation of inducible nitric oxide synthase gene expression in vascular smooth 
muscle cells. Gen Pharmacol 32, 9–16 (1999).
14. Kleinert, H., Euchenhofer, C., Ihrig-Biedert, I. & Forstermann, U. In murine 3T3 fibroblasts, different second messenger pathways 
resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kappaB. The Journal of 
biological chemistry 271, 6039–6044 (1996).
15. Kleinert, H. et al. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-
signaling pathways. Br J Pharmacol 125, 193–201 (1998).
16. Marks-Konczalik, J., Chu, S. C. & Moss, J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase 
gene requires both activator protein 1 and nuclear factor kappaB-binding sites. The Journal of biological chemistry 273, 22201–22208 
(1998).
17. Aktan, F. iNOS-mediated nitric oxide production and its regulation. Life Sci 75, 639–653 (2004).
18. Deguine, J. & Barton, G. M. MyD88: a central player in innate immune signaling. F1000Prime Rep 6, 97 (2014).
19. Narayanan, K. B. & Park, H. H. Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways. Apoptosis 20, 
196–209 (2015).
20. Bogdan, C. Nitric oxide and the regulation of gene expression. Trends Cell Biol 11, 66–75 (2001).
21. Kamijo, R. et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (New York, N.Y) 263, 
1612–1615 (1994).
22. Lowenstein, C. J. et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and 
lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 90, 9730–9734 (1993).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7:41686 | DOI: 10.1038/srep41686
23. Kim, Y. I., Park, S. W., Kang, I. J., Shin, M. K. & Lee, M. H. Activin suppresses LPS-induced Toll-like receptor, cytokine and inducible 
nitric oxide synthase expression in normal human melanocytes by inhibiting NF-kappaB and MAPK pathway activation. Int J Mol 
Med 36, 1165–1172 (2015).
24. Cuzzocrea, S. et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135, 
496–510 (2002).
25. Lage, S. L. et al. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage 
responses. Proceedings of the National Academy of Sciences of the United States of America 110, E3321–3330 (2013).
26. Erener, S. et al. Inflammasome-Activated Caspase 7 Cleaves PARP1 to Enhance the Expression of a Subset of NF-kappaB Target 
Genes. Molecular cell 46, 200–211 (2012).
27. Garber, M. et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in 
mammals. Molecular cell 47, 810–822 (2012).
28. Lupfer, C., Malik, A. & Kanneganti, T. D. Inflammasome control of viral infection. Curr Opin Virol 12, 38–46 (2015).
29. Ulland, T. K., Ferguson, P. J. & Sutterwala, F. S. Evasion of inflammasome activation by microbial pathogens. The Journal of clinical 
investigation 125, 469–477 (2015).
30. van de Veerdonk, F. L., Joosten, L. A. & Netea, M. G. The interplay between inflammasome activation and antifungal host defense. 
Immunol Rev 265, 172–180 (2015).
31. Zamboni, D. S. & Lima-Junior, D. S. Inflammasomes in host response to protozoan parasites. Immunol Rev 265, 156–171 (2015).
32. Lima-Junior, D. S. et al. Inflammasome-derived IL-1beta production induces nitric oxide-mediated resistance to Leishmania. Nat 
Med 19, 909–915 (2013).
33. Ghasemi, M. & Fatemi, A. Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases. Neurosci Biobehav 
Rev 45, 168–182 (2014).
34. Ten Broeke, R. et al. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res 7, 
58 (2006).
35. Xu, C., Yi, C., Wang, H., Bruce, I. C. & Xia, Q. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression 
by nitric oxide overproduction and mitochondrial permeability transition pore opening. Shock 37, 110–115 (2012).
36. Mangge, H., Becker, K., Fuchs, D. & Gostner, J. M. Antioxidants, inflammation and cardiovascular disease. World J Cardiol 6, 
462–477 (2014).
37. Dupont, L. L., Glynos, C., Bracke, K. R., Brouckaert, P. & Brusselle, G. G. Role of the nitric oxide-soluble guanylyl cyclase pathway 
in obstructive airway diseases. Pulm Pharmacol Ther 29, 1–6 (2014).
38. Malireddi, R. K., Ippagunta, S., Lamkanfi, M. & Kanneganti, T. D. Cutting edge: proteolytic inactivation of poly(ADP-ribose) 
polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes. J Immunol 185, 3127–3130 (2010).
39. Hassa, P. O., Haenni, S. S., Elser, M. & Hottiger, M. O. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today 
and where are we going? Microbiol Mol Biol Rev 70, 789–829 (2006).
40. Kim, M. Y., Zhang, T. & Kraus, W. L. Poly(ADP-ribosyl) ation by PARP-1: ‘PAR-laying’ NAD+ into a nuclear signal. Genes Dev 19, 
1951–1967 (2005).
41. D’Amours, D., Sallmann, F. R., Dixit, V. M. & Poirier, G. G. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by 
apoptotic proteases: implications for apoptosis. J Cell Sci 114, 3771–3778 (2001).
42. Kraus, W. L. & Lis, J. T. PARP goes transcription. Cell 113, 677–683 (2003).
43. Krishnakumar, R. & Kraus, W. L. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. 
Molecular cell 39, 736–749 (2010).
44. Petrilli, V. et al. Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. The Journal of clinical 
investigation 114, 1072–1081 (2004).
45. Hottiger, M. O. Poly(ADP-ribose) polymerase inhibitor therapeutic effect: are we just scratching the surface? Expert Opin Ther 
Targets 19, 1149–1152 (2015).
46. Petrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell death and 
differentiation 14, 1583–1589 (2007).
47. Weinlich, R. et al. TLR4/MYD88-dependent, LPS-induced synthesis of PGE2 by macrophages or dendritic cells prevents anti-CD3-
mediated CD95L upregulation in T cells. Cell death and differentiation 15, 1901–1909 (2008).
Acknowledgements
We thank Drs Roberta Minotti and Mareike Hesse for helping with the qPCR assays, and Eduardo Pinheiro 
Amaral for the criticism and discussions. ADP-ribosylation research in the laboratory of MOH is funded by 
the Kanton of Zurich, the University Research Priority Program (URPP) in Translational Cancer Biology at the 
University of Zurich, and the Swiss National Science Foundation (grant 310030B_138667). Work in D.D.C.’s 
laboratory is supported by grants from the Cancer Research Society (CRS19092 and CRS19091), Canadian 
Cancer Society (CCSRI 703279 and CCSRI 703716), NSERC (489073), Ontario Institute for Cancer Research 
(OICR) with funds from the province of Ontario, the Princess Margaret Cancer Foundation, and the University 
of Toronto McLaughlin Centre (MC-2015-02). This work was supported by Fundação de Amparo à Pesquisa 
do Estado de São Paulo (FAPESP – Brazil) Proc 2013/16010-5 and 2015/18003-1; Brazilian Research Council 
(CNPq-Brazil), CAPES and INCTV.
Author Contributions
K.R.B. supervised the project; M.O.H., D.D.C. and K.R.B. designed research; C.L.B., T.M., L.M.B. and S.L.L. 
performed research; L.C.S.F., M.O.H. and D.D.C. contributed new reagents/analytic tools; C.L.B., T.M., G.P.A-M., 
D.D.C. and K.R.B. analyzed data; C.L.B., G.P.A-M, D.D.C. and K.R.B. wrote the paper.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Buzzo, C. L. et al. Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by 
NLRC4 inflammasomes involves PARP1 cleavage. Sci. Rep. 7, 41686; doi: 10.1038/srep41686 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
www.nature.com/scientificreports/
1 2Scientific RepoRts | 7:41686 | DOI: 10.1038/srep41686
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
